Sanofi SA (SNY) Stock Price Today
Aura AI Summary
Key Stats
- $102.77BMarket Cap
- 2,426,750Volume
- HealthSector
- $52.3452W High
- $41.3352W Low
- 93 DaysTypical Hold Time
- $122.64BEnterprise Value
- 5.68%Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Sanofi SA (SNY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Sanofi SA has traded between a low of $41.33 and a high of $52.34, highlighting its annual price range. Buy and sell Sanofi SA shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Most Recent News
Five Below CHRO Maureen Gellerman sells 1,610 shares for $401,000
Maureen Gellerman, Chief Human Resources Officer at Five Below, sold 1,610 shares of the company, generating $401,000 from the transaction. This insider sale may indicate personal financial planning or portfolio rebalancing but does not necessarily r...
ON Semiconductor drives AI and EV growth with new power tech and a 2030 vision despite neutral rating.
ON Semiconductor is focusing on advanced power-density technologies for AI data centers and electric vehicles, aiming for $2.5 billion revenue from AI alone by 2030. Despite a Neutral rating from UBS, the company introduced its Embedded Power Platfor...
Boeing shares drop as 737 MAX production delays raise investor costs despite strong backlog.
Boeing's CEO revealed that stabilizing 737 MAX production is delayed, causing shares to fall 3.64%. While management maintains a $1-$3 billion free cash flow target for 2026 and a long-term $10 billion goal, higher interest rates mean delayed cash fl...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.